John Wayne Cancer Center

Santa Monica, California 90404

0 studies enrolling now · 2 studies all time

What they study most

Malignant Melanoma, Pan Tumor

Studies at this site

• A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) — Completed
• UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma — Completed